Erich Bluhmki und Christoph Wanner - Info zur Person

(1 - 10 von 10

)

Rationale, design, and baseline OPUS Würzburgopus.bibliothek.uni-wuerzburg.de › ...

opus.bibliothek.uni-wuerzburg.de

Bernard Zinman, Silvio E. Inzucchi, John M. Lachin, Christoph Wanner, Roberto Ferrari, David Fitchett, Erich Bluhmki, Stefan Hantel, Joan ...

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2...

www.scienceopen.com

Authors: Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, ...

Diabetes drug reduces risk of heart failure and may prevent it, study...

www.sciencedaily.com

Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Silvio E. Inzucchi. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. New England Journal of ...

OPUS Würzburg | Rationale, design, and baseline characteristics of a...

opus.bibliothek.uni-wuerzburg.de

... and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME (TM)). Bernard Zinman, Silvio E. Inzucchi, John M. Lachin, Christoph Wanner, Roberto Ferrari, David Fitchett, Erich Bluhmki, Stefan Hantel, Joan Kempthorne-Rawson, ...

Seguridad cardiovascular de la empaglifozina en la diabetes mellitus...

secardiologia.es

Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd ...

"Empagliflozin, cardiovascular outcomes, and mortality in type 2...

hsrc.himmelfarb.gwu.edu

By Bernard Zinman, Christoph Wanner, John M. Lachin, et al., Published on

CoCited Articles Page - CoCitescocites.com › coCitedArticles

cocites.com

Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans ...

GW Biostatistics Center | George Washington University Biostatistics...

hsrc.himmelfarb.gwu.edu

Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes., Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, ...

Improved cardiovascular outcomes with empagliflozin treatment |...

www.cardio-debate.com

1. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. Bernard Zinman, M.D., Christoph Wanner, M.D., John M. Lachin, Sc.D., David Fitchett, M.D., Erich Bluhmki, Ph.D., Stefan Hantel, Ph.D., Michaela Mattheus, Dipl. Biomath., Theresa Devins, Dr.P.H., Odd Erik Johansen, M.D., Ph.D., ...

Alle Infos zum Namen "Erich Bluhmki"

Verwandte Suchanfragen zu Erich Bluhmki

Erik Johansen
Werner Hacke
Michaela Mattheus

Thomas Brott
Dietmar Schneider
Stefan Hantel

Geoffrey Donnan
Christoph Wanner
Geoff Cohen

Personen
Vorname "Erich" (17990)
Name "Bluhmki" (14)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Erich Bluhmki und Christoph Wanner Person-Info